secwatch.observer — SEC 8-K summary
======================================

Issuer:     AtriCure, Inc. (ATRC)
CIK:        0001323885
Form:       8-K/A
Filed at:   2026-05-06T23:59:59+00:00
Accession:  0001323885-26-000020
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AtriCure Q1 revenue $141.2M (+14.3%); corrects FY2026 guidance to rev $600-610M, adj EBITDA $80-82M
--------------------------------------------------------------------------------

- Q1 revenue $141.2M (+14.3% YoY); net income $0.1M, breakeven EPS.
- U.S. rev growth 14.9% driven by cryoSPHERE MAX, AtriClip FLEX-Mini, EnCompass clamp.
- Adjusted EBITDA $17.1M, up 95% YoY; gross margin 77.4% (+246 bps).
- Corrected FY2026 guidance: revenue $600-610M, adj EBITDA $80-82M, adj EPS $0.09-0.15, net EPS $0.00-0.04.
- International revenue $25.0M (+11.5% as reported; +3.3% constant currency).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1323885/000132388526000020/0001323885-26-000020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1323885/000132388526000020/atrc-20260505.htm
  HTML page:      https://secwatch.observer/filing/0001323885-26-000020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer